Back
SGMT
SAGIMET BIOSCIENCES INC.
๐บ๐ธ NYSE/NASDAQ
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-34.33%
Annual Growth
2 years average annual capital growth
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company developing fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. The Company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction associated steatohepatitis (MASH). Denifanstat has been granted Breakthrough Therapy designation by the FDA for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis. The Company is also exploring the use of its FASN inhibitors, which include denifanstat and its pipeline product candidate, TVB-3567, in acne and in select forms of cancer. Denifanstat is being tested in China by its license partner, Ascletis BioScience Co. Ltd., for moderate to severe acne vulgaris and recurrent glioblastoma multiforme in combination with bevacizumab.
๐ Performance
Price History*
-65.36%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$5.56
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in SGMT
1
๐ Total Capital Earnings
N/A
๐ Average investment frequency
18 weeks
๐ต Average investment amount
$330
โฐ Last time a customer invested in SGMT
160 days
SGMT investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
100%
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
100%
๐ Legal gender of investors
Female
100%
Male
Pearlers who invest in SGMT also invest in...
๐ Performance (5Yr p.a)
38.66%
๐ Share price
$33.64 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
8.05%
๐ Share price
$48.36 USD
๐ HIGH PRICE GROWTH
๐ Performance (5Yr p.a)
-10.04%
๐ Share price
$95.66 USD
Want more shares? Try these...
๐ Performance (5Yr p.a)
-19.02%
๐ Share price